個股熱度排行 | 2月4日美股盤前
根據uSMART輿情監測數據,從3日晚間到4日美股盤前時間段,中國投資者關注指數最高的5只股票是Meta Platforms、阿裏巴巴、福特汽車、百濟神州、生化基因。
2月4日—美股關注排行TOP5

Meta Platforms

關注度第一爲Meta Platforms,該股上個交易日收盤下跌26.39%,報於237.76美元。近5個交易日累計下跌19.30%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
納指跌逾3.7%,Meta創美股史上單日最大個股市值縮水規模
Facebook母企Meta上季遜預期 股價挫逾26%
阿裏巴巴

關注度第二爲阿裏巴巴,該股上個交易日收盤上漲0.48%,報於123.47美元。近5個交易日累計上漲10.45%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
恆指漲2.48% 阿裏巴巴-SW高開逾5%領漲藍籌
恆指升645點; 恆生科技指數升123點 友邦升逾4% 阿裏巴巴升逾4% 平安升逾4% 匯控、中銀香港創新高
福特汽車

關注度第三爲福特汽車,該股上個交易日收盤下跌3.59%,報於19.89美元。近5個交易日累計上漲1.74%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
福特汽車季績遜色 盤後股價跌4%
福特汽車盤前跌5.18% 利潤遠低於市場預期
百濟神州

關注度第四爲百濟神州,該股上個交易日收盤下跌9.00%,報於223.50美元。近5個交易日累計上漲10.15%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
百濟神州委任Alessandro Riva等爲獨立非執行董事
百濟神州因受限制股份單位獲歸屬發行35.22萬股
生化基因

關注度第五爲生化基因,該股上個交易日收盤下跌2.13%,報於220.17美元。近5個交易日累計上漲0.56%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
Biogen阿茲海默症藥季度銷售遠遜預期
百健料今年利潤估計較分析員低
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.